SCHEMBL1965682

SCHEMBL1965682

COC(=O)CC(C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14196343 0.91 TSHR (0.39)
SCHEMBL15910179 0.84 TSHR (0.46)
SCHEMBL11911037 0.83 MGAM (0.42)
SCHEMBL24242166 0.80 LMNA (0.42)
SCHEMBL7054842 0.80
SCHEMBL11911038 0.80 TSHR (0.37)
SCHEMBL5692410 0.78 MGAM (0.48)
SCHEMBL7691229 0.78 TSHR (0.48)
SCHEMBL18760222 0.78 TSHR (0.48)
SCHEMBL18348181 0.78 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217899-A Method for efficiently degrading poly 3-hydroxybutyrate at room temperature 东莞理工学院 2023-06-06 CN claimed
CN-109313388-A Negative photosensitive composition 普罗米鲁斯有限责任公司 2019-02-05 CN claimed
WO-2025048226-A1 COMPOSITION FOR NON-AQUEOUS ELECTROLYTE, AND ELECTROCHEMICAL CELL COMPRISING COMPOSITION 주식회사 리베스트 2025-03-06 WO disclosed
US-11801234-B2 Methods of treating APOL-1 dependent focal segmental glomerulosclerosis VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-31 US disclosed
US-20230322675-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY LHOTSE BIO, INC. 2023-10-12 US disclosed
US-20230271945-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-08-31 US disclosed
US-20230265080-A1 MODULATORS OF ALPHA-1 ANTITRYPSIN VERTEX PHARMA (US) 2023-08-24 US disclosed
US-20230250087-A1 SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-08-10 US disclosed
CN-116217899-A Method for efficiently degrading poly 3-hydroxybutyrate at room temperature 东莞理工学院 2023-06-06 CN disclosed
CN-116217899-A Method for efficiently degrading poly 3-hydroxybutyrate at room temperature 东莞理工学院 2023-06-06 CN disclosed
US-20220221798-A1 STORAGE CONTAINER STORING TREATMENT LIQUID FOR MANUFACTURING SEMICONDUCTOR FUJIFILM CORPORATION (JP) 2022-07-14 US disclosed
EP-0726500-A1 Chemically amplified, radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1996-08-14 EP disclosed
EP-0660187-A1 Radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1995-06-28 EP disclosed
US-5250729-A Process for preparing unsaturated carboxylic acid or ester thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1993-10-05 US disclosed
EP-0379691-A1 Process for preparing unsaturated carboxylic acid or ester thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1990-08-01 EP disclosed
US-4424375-A ORGANIC HALIDE, CARBOXYLIC ESTER OR SALT DYNAMIT NOBEL AG (DE) 1984-01-03 US disclosed
US-4156785-A FROM AN UNSATURATED HALOGEN COMPOUND, CARBON MONOXIDE AND AN ALKALI METAL ALCOHOLATE USING NICKEL OR COBALT CARBONYL AS CATALYST DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) 1979-05-29 US disclosed
US-3987089-A PLATINUM GROUP METAL SALT CATALYST, REOXIDIZING AGENT ROHM AND HAAS COMPANY (US) 1976-10-19 US disclosed
US-3980697-A SOLVENTS FOR POLYMERS AND PLASTICIZERS DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed
US-3960934-A METAL HALIDE CATALYST ROHM GMBH (DT) 1976-06-01 US disclosed